Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocular Therapeut (NQ: OCUL )

6.355 +0.075 (+1.19%)
Streaming Delayed Price Updated: 2:38 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 466,638
Open 6.340
Bid (Size) 6.350 (7)
Ask (Size) 6.360 (8)
Prev. Close 6.280
Today's Range 6.290 - 6.460
52wk Range 2.570 - 7.320
Shares Outstanding 77,524,666
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Ratings for Ocular Therapeutix
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga

Performance

YTD
+127.78%
+127.78%
1 Month
+2.83%
+2.83%
3 Month
+6.63%
+6.63%
6 Month
+119.14%
+119.14%
1 Year
+103.04%
+103.04%

More News

Read More
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments
Via FinancialNewsMedia
Exposures COVID-19
What 5 Analyst Ratings Have To Say About Ocular Therapeutix
Via Benzinga
Looking Into Ocular Therapeutix's Return On Capital Employed
Via Benzinga
The Latest Analyst Ratings for Ocular Therapeutix
Via Benzinga
Earnings Outlook For Ocular Therapeutix
Via Benzinga
Why Shares of Ocular Therapeutix Jumped This Week
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
Via Benzinga
OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay
Via Benzinga
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
Via Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Tesla, Solaredge, Palantir, Cleveland-Cliffs, Ocular Therapeutix: Why These 5 Stocks Are Drawing Heavy Attention Today
Via Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
Via Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
Via Benzinga
Teradata, Monday.Com And Other Big Stocks Moving Higher On Monday
Via Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Ocular Therapeutix Shares Jump On Favorable Data From Intravitreal Implant Study In Wet AMD
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.